**Research Highlights**

(1)0.25, 0.062 5, and 0.015 6 mg/mL n-butanol extract of *Potentilla anserine* L. increased the viability of in vitro hypoxic hippocampal neurons from neonatal rats.(2)0.25, 0.062 5, and 0.015 6 mg/mL n-butanol extract of *Potentilla anserine* L. attenuated the expression of caspase-9 and caspase-3 in hypoxic hippocampal neurons.(3)0.25, 0.062 5, and 0.015 6 mg/mL n-butanol extract of *Potentilla anserine* L. decreased the release of cytochrome c in hypoxic hippocampal neurons.

**Abbreviations** MAP2, microtubule-associated protein 2; MPTP, mitochondrial permeability transition pore

INTRODUCTION {#sec1-1}
============

Neurons die from hypoxia or hypoxia-ischemia much faster than other cell types\[[@ref1]\]. Extensive studies have indicated that mitochondrial injury is the central cause of hypoxic brain injury\[[@ref2][@ref3][@ref4]\]. After hypoxia, cytochrome c in the mitochondria is released, and results in the opening of the mitochondrial permeability transition pore\[[@ref5][@ref6]\], thus triggering the caspase cascade. Caspase-9 is the major initiator caspase of the intrinsic mitochondrial apoptotic pathway\[[@ref7][@ref8]\]. Caspase-3 acts as the final executor of cell death and is also activated in hypoxic neurons\[[@ref9][@ref10]\]. Caspase inhibitors can reduce hypoxia or hypoxia-ischemia induced neuronal death\[[@ref11][@ref12][@ref13]\].

*Potentilla anserina* L., commonly called the monorchid herminium herb, belongs to the Rosaceae family and contains polysaccharides, amylum, fatty acids, essential amino acids, and vitamins. *Potentilla anserina* L. possesses a high medical and nutritional value, and has been used as a crude drug and a Chinese herbal medicine in Tibet, China. Recent studies have shown that *Potentilla anserina* L. strengthens immunity, exhibits anti-oxidative activity, and anti-hypoxic properties\[[@ref14][@ref15][@ref16]\]. A previous study showed that the alcohol extract of *Potentilla anserina* L. could protect myocardium cells from ischemic or ischemic/reperfusion injury *in vitro* and *in vivo* \[[@ref17][@ref18][@ref19]\]. In particular its n-butanol extract, an effective part of the alcohol extract, could remarkably protect the myocardium from acute ischemic injury\[[@ref20][@ref21]\]. However, its effects on rat hippocampal neurons and the mechanism of this protection are not yet well understood. In the present study, we investigated the effects of the n-butanol extract of *Potentilla anserina* L. on hypoxic injury induced by low oxygen density in primary hippocampal neurons. The effects of *Potentilla anserina* L. were then compared with tanshinone IIA, which has been shown to be neuroprotective\[[@ref22][@ref23][@ref24][@ref25][@ref26][@ref27]\].

RESULTS {#sec1-2}
=======

Morphology of primary cultured hippocampal neurons {#sec2-1}
--------------------------------------------------

After 7 days in culture, neurons were plump, strongly refractory, displayed central cell nuclei and nucleoli were clearly visible. Neuronal processes were interwoven into a thick network ([Figure 1A](#F1){ref-type="fig"}).

![Effects of the n-butanol fraction of *Potentilla anserine* L. on the viability of hypoxic hippocampal neurons. Primary cultured hippocampal neurons were pre-incubated with different concentrations of *Potentilla anserine* L. (0, 0.25, 0.062 5, 0.015 6 mg/mL) for 24 hours and then exposed to 0.1% desired oxygen concentration for 4 hours. The neurons in the control group were not treated with *Potentilla anserine* L. and hypoxia.\
(A) Normal neuronal morphology under optic microscopy (scale bar: 40 μm).\
(B) Hippocampal neurons were identified using immunocytochemistry for microtubule associated protein 2. Green arrows indicate positive stained cells (scale bar: 40 μm).\
(C) Neuronal viability was determined using MTT assay. Data are expressed as mean ± SEM (*n* = 12). Differences between the means were determined by one-way analysis of variance followed by a Student-Newman-Keuls test for multiple comparisons. ^a^*P* \< 0.01, *vs.* control group; ^b^*P* \< 0.01, *vs.* model group.](NRR-7-2576-g001){#F1}

Microtubule-associated protein 2 (MAP2) is an abundant neuronal cytoskeletal protein that binds to tubulin and stabilizes microtubules\[[@ref28]\]. MAP2 is essential for the development and maintenance of neuronal morphology\[[@ref29]\]. MAP2 was abundantly expressed in hippocampal neurons, and seldom expressed in gliocytes. The purity of primary cultured hippocampal neurons was identified by immunocytochemistry using MAP2. Results showed that the proportion of positively stained cells reached 75.2 ± 8.1% ([Figure 1B](#F1){ref-type="fig"}). These cells were then used for subsequent research.

Pretreatment with n-butanol extract of *Potentilla anserine* L. significantly increased cell viability in hypoxic hippocampal neurons {#sec2-2}
-------------------------------------------------------------------------------------------------------------------------------------

Cell viability was verified by MTT assay. Hypoxia led to a decrease in neuron cell viability (*P* \< 0.01, *versus* the control group). Decreased neuronal viability was suppressed by pretreatment with the n-butanol extract of *Potentilla anserine* L. (*P* \< 0.01, *versus* the model group). The 0.25 mg/mL dosage group showed increasing viability compared with 0.062 5 mg/mL dosage groups (*P* \< 0.05). Moreover, pretreatment with tanshinone IIA could also increase the viability of hippocampal neurons under hypoxia (*P* \< 0.01, *versus* the model group; [Figure 1C](#F1){ref-type="fig"}).

n-butanol extract of *Potentilla anserine* L. significantly decreased the release of cytochrome c and attenuated the expression of caspase-9 and caspase-3 in hypoxic hippocampal neurons {#sec2-3}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Reverse transcription-PCR results showed that the expression levels of caspase-9 and caspase-3 mRNA were very low in the control group. Hypoxia strongly induced the activation of caspase-9 and caspase-3 mRNA in hippocampal neurons (*P* \< 0.01, *versus* the control group). Each dosage of *Potentilla anserine* L. extract could significantly reduce the expression of caspase-9 and caspase-3 mRNA in hypoxic-neurons (*P* \< 0.01, *versus* the model group; [Figure 2](#F2){ref-type="fig"}).

![Change in caspase-9 (A) and caspase-3 (B) mRNA levels in hippocampal neurons.\
The loading bands from left to right are model group, control group, tanshinone IIA group, *Potentilla anserine* L. 0.25 mg/mL group, *Potentilla anserine* L. 0.062 5 mg/mL group, and *Potentilla anserine* L. 0.015 6 mg/mL group.\
Data are expressed as absorbance ratio of target gene to β-actin (mean ± SEM, *n* = 3). Differences between the means were determined by one-way analysis of variance followed by a Student-Newman-Keuls test for multiple comparisons. ^a^*P* \< 0.01, *vs.* control group; ^b^*P* \< 0.01, *vs.* model group. A representative experiment is shown.\
I: Model group; II: control group; III: transhinone IIA group; IV: *Potentilla anserine* L. 0.25 mg/mL; V: *Potentilla anserine* L. 0.062 5 mg/mL group; VI: Potentilla *anserine* L. 0.015 6 mg/mL group.](NRR-7-2576-g002){#F2}

Western blot revealed that protein expression levels of cytochrome c, Caspase-9 and Caspase-3 were very low in the control group. Hypoxia strongly induced the expressions of cytochrome c, Caspase-9 and Caspase-3 in hippocampal neurons (*P* \< 0.01, *versus* the control group). Pretreatment with *Potentilla anserine* L. extract or tanshinone IIA could significantly decrease the expression of Caspase-9 and Caspase-3 (*P* \< 0.01 or 0.05, *versus* the model group; [Figure 3](#F3){ref-type="fig"}). However, pretreatment with tanshinone did not decrease the expression of cytochrome c (*P* \< 0.01; [Figure 3](#F3){ref-type="fig"}).

![Change in cytochrome c, Caspase-9 and Caspase-3 expression in hippocampal neurons analyzed using western blot assay.\
(A) Representative western blot bands of cytochrome c, Caspase-9 and Caspase-3 expression in different treated groups. The loading bands from left to right are marker, model group, control group, tanshinone IIA group, *Potentilla anserine* L. 0.25 mg/mL group, *Potentilla anserine* L. 0.062 5 mg/mL group, and *Potentilla anserine* L. 0.015 6 mg/mL group.\
(B--D) Quantification of cytochrome c, Caspase-3, and Caspase-9 expression. Data are expressed as absorbance ratio of target protein to β-actin (mean ± SEM, *n* = 3). Differences between the means were determined by one-way analysis of variance followed by a Student- Newman-Keuls test for multiple comparisons. ^a^*P* \< 0.01, *vs.* control group; ^b^*P* \< 0.01, ^c^*P* \< 0.05, *vs.* model group.\
I: Control group; II: model group; III: transhinone IIA group; IV: *Potentilla anserine* L. 0.25 mg/mL; V: *Potentilla anserine* L. 0.062 5 mg/mL group; VI: *Potentilla* *anserine* L. 0.015 6 mg/mL group.](NRR-7-2576-g003){#F3}

DISCUSSION {#sec1-3}
==========

Mitochondrial injury is a major contributor to hypoxic brain injury as it connects upstream and downstream signal transmission. After hypoxia, electron transfer in the mitochondrial respiratory chain is hindered and energy metabolism is obstructed. Cytochrome c in the mitochondria is released and reactive oxygen species are generated, resulting in the opening of the mitochondrial permeability transition pore. The released cytochrome c from the mitochondria induces cell death in two ways. First, it triggers the caspase cascade.

Caspases, cysteine-dependent protein kinases, are the most important enzymes in cell death. Cytochrome c can associate with apoptosis protease activating factor and pro-caspase 9, and triggers the activation of caspase-3 and apoptosis\[[@ref30][@ref31]\]. Caspase-3 can specifically cleave Bcl-2, resulting in the loss of inhibitory effect on mitochondrial permeability transition pore, thus releasing more cytochrome c\[[@ref32][@ref33][@ref34]\]. Second, it interrupts the electron transport chain, and thereby inhibits oxidative phosphorylation; this generates oxygen free radicals and results in a lack of ATP and eventually cell death. The caspase-dependent pathway is the faster process leading to cell death. In addition, hypoxic stress also leads to activation of caspase-8, which elicits the release of cytochrome c into the cytosol and activates the release of other caspases. This process initiates internucleosomal DNA fragmentation and results in apoptosis\[[@ref35][@ref36]\].

Mitochondrial cell death can occur due to apoptosis and necrosis. Hypoxic/ischemic brain injury induces cell death in neurons by apoptotic and necrotic mechanisms\[[@ref37]\]. Apoptosis and necrosis are initially identified by two different modes, based on the morphological criteria. Caspases are essential for the execution steps in apoptosis\[[@ref38]\]. Caspase-9 is the major initiator caspase of the intrinsic mitochondrial apoptotic pathway, and its inhibition in the brain by LEHD-CHO (Caspase-9 inhibitor) has been demonstrated to have a neuroprotective effect. Caspase-9 is important in the pathophysiology of hypoxic/ischemic neuronal destruction in newborn rats\[[@ref39]\]. Caspase-3 acts as the final executor of cell death and is also activated in hypoxic neurons. Caspases may also be expressed in the context of necrotic cell death\[[@ref40]\]. Necrosis is generally considered to occur because of an external stimulus (changes in ion flux), but recent studies have shown that neuronal death after oxygen ion flux is far from passive cell swelling and dissolution, but requires an orderly activated cell death program. Necrosis may be triggered by mitochondrial dysfunction, subsequently leading to the release of cytochrome c and the activation of the caspase system. This means that apoptosis and necrosis have the same final pathway. This involves mitochondrial dysfunction caused by cytochrome c release followed by the activation of Caspase-9 and Caspase-3 by cytochrome c, along with apoptosis protease activating factor-1. This activation is followed by hydrolysis, and finally the activation of the caspase kinase system occurs. However, in the process of apoptosis, gene expression and protein synthesis requires a large of amount energy. During hypoxia, ischemia, or any other low-energy state, the huge amount of energy required for protein synthesis cannot be met. By contrast, caspases exist in normal cells, and activation requires only a small amount of energy; therefore, in hypoxia, necrosis may be the main cause of cell death\[[@ref41]\].

In this study, expression levels of caspase-9 mRNA and caspase-3 mRNA were very low in the control group. Hypoxia strongly induced the activation of caspase-9 and caspase-3 in neurons. However, pretreatment with *Potentilla anserine* L. extract significantly reduced the expression of caspase-9 mRNA and caspase-3 mRNA in hypoxic-neurons. Likewise, similar results were observed for the expression of Caspase-9 and Caspase-3 protein. Pretreatment with *Potentilla anserine* L. extract also significantly decreased the release of cytochrome c into the cytosol. These findings suggested that the n-butanol extract of *Potentilla anserine* L. could protect primary hippocampal neurons from hypoxic injury by attenuating mitochondrial cell death. Oxygen free radicals are a main cause of mitochondrial injury. Our previous studies demonstrate that *Potentilla anserina* L. exhibits anti-oxidative activity\[[@ref16][@ref20]\]. This activity may contribute to the mitochondrial protective effect of *Potentilla anserina* L.

In summary, our findings demonstrate that the n-butanol extract of *Potentilla anserine* L. has a neuroprotective effect on hypoxic injury in primary hippocampal neurons. The possible mechanism is as follows: the n-butanol extract of *Potentilla anserine* L. protects mitochondrial function by attenuating the release of cytochrome c into the cytosol, and thereby inhibits the caspase cascade pathway. This prevents cell death. These findings provide a theoretical basis for developing the n-butanol extract of *Potentilla anserine* L. as a neuroprotective agent.

MATERIALS AND METHODS {#sec1-4}
=====================

Design {#sec2-4}
------

A cytological comparison study.

Time and setting {#sec2-5}
----------------

Experiments were performed at the Department of Medicinal Chemistry, Medical College of Chinese People\'s Armed Police Forces, Tianjin, China from May 2008 to January 2011.

Materials {#sec2-6}
---------

### Animals {#sec3-1}

Fifty pregnant Sprague-Dawley clean grade rats were purchased from the Laboratory Animal Center of Academy of Military Medical Sciences, China, permission No. SCXK (Army) 2002-001. Neonatal mice (within 24 hours of birth) were used for this study. All experiments were performed in accordance with the *Guidance Suggestions for the Care and Use of Laboratory Animals*, issued by the Ministry of Science and Technology of China\[[@ref42]\].

### Drugs {#sec3-2}

*Potentilla anserine* L. was purchased from Qinghai Institute of Chinese Medicine, China. The n-butanol extract of *Potentilla anserine* L. was extracted as previously described\[[@ref20]\]. Five compounds have been isolated from the extract, which were considered as contributors to the protective function of anti-hypoxia in neurons. They are adenosine, daidzin, puerarin, 3'-methoxypuerarin and daidzein 8-C-apiosyl glucoside.

Tanshinone IIA (Huike Botanical Development Co., Shaanxi, China) with a purity of more than 98%, was dissolved in 0.1% dimethyl sulfoxide and made up to a concentration of 20 mg/mL in D-Hank\'s medium (Gibco, Grand Island, NY, USA).

Methods {#sec2-7}
-------

### Primary hippocampal neuron cultures {#sec3-3}

Sprague-Dawley neonatal rats were anesthetized with diethyl ether and disinfected with 75% alcohol. Primary hippocampal neurons were prepared from the hippocampus under sterile conditions\[[@ref43]\]. Neurons were suspended in a culture medium that contained DMEM-F12 (Gibco), fetal bovine serum, mycillin, and glucose (4 × 10^5^ cell/mL), and then plated onto poly-D-lysine-coated 60 mm dishes. The medium was changed after 48 hours by replacing the fetal bovine serum with N2 (Gibco), and half of the medium was replaced every 3 days. The cells were cultured in a CO~2~ incubator at 37°C and 5% CO~2~. After 7 days in culture, observation under a phase-contrast microscope (Olympus, Tokyo, Japan) demonstrated that cells were predominantly neurons (\> 96%). All experiments were performed after cells were cultured for 7 days.

### The purity of primary cultured hippocampal neurons identified by immunocytochemical analysis {#sec3-4}

Cultured cells were fixed in 4% paraformaldehyde, permeabilized in 0.1% Triton X-100, and blocked in 5% bovine serum albumin. MAP2 was detected with rabbit anti-MAP2 polyclonal antibody (1:100; Cell Signaling Technology, Beverly, MA, USA), and primary antibodies were incubated overnight at 4°C, followed by goat anti-rabbit secondary antibodies (Invitrogen, Grand Island, NY, USA). 3,3-diaminobenzidine was then used to visualize immunohistochemical staining. Cell nuclei were then counterstained with hematoxylin. Images were obtained with an Olympus BX51 microscope (Olympus) and the proportion of positive staining cells was analyzed with Image-Pro plus 5.1 software (Bethesda, MD, USA)\[[@ref28][@ref29]\].

### Grouping and intervention {#sec3-5}

Culture dishes were randomly divided into the control, hypoxic injury model, and the 0.25, 0.062 5, and 0.015 6 mg/mL of n-butanol extract of *Potentilla anserine* L. groups. These concentrations were chosen based on previous studies\[[@ref20]\]. Tanshinone IIA, a positive control, was preincubated before hypoxia at a working concentration of 0.2 mg/mL. After 7 days of culture, control dishes were kept in normoxic conditions. D-Hank\'s medium with different concentrations of the extract was used for the hypoxic injury model group and the intervention group. D-Hank\'s medium with extract was initially placed in a hypoxic environment (95% N~2~, 5% CO~2~) for 30 minutes and then replaced with normal medium. The model and intervention groups were then exposed to a 95% N~2~, 5% CO~2~ air mixture for 4 hours.

### Viability of hippocampal neurons determined using MTT assay {#sec3-6}

Neuronal viability was assessed using MTT assay as previously described\[[@ref44]\], with some modifications. The yellow MTT was reduced to a purple formazan by mitochondrial dehydrogenase in live cells. Briefly, a total of 5 mg/mL MTT was added to each well (final concentration was 1 mg/mL) and another 4 hours of incubation at 37°C was conducted. The assay was stopped by the addition of a 100 μL lysine buffer (20% SDS in 50% N, N- dimethylformamide, pH 4.7). Absorbance value was measured at 570 nm with ELX-800 microplate assay reader (BioTek, Winooski, VT, USA).

### Determination of caspase-9, caspase-3 mRNA in hippocampal neurons by reverse transcription-PCR {#sec3-7}

The total RNA were extracted from neurons using TRIzol reagent (Gibco), and its purity and integrity were measured. The primers (Invitrogen) were as follows: caspase-9, F: 5'-CCC GTG AAG CAA GGA TTT-3', R: 5'-TCT GTG GGT CTG GGA AGC-3'; caspase-3, F: 5'-GCA CTG GAA TGT CAG CTC GCA A-3', R:5'-GCC ACC TTC CGG TTA ACA CGA C-3'; β-actin, F: 5'-TGA TGA CAT CAA GAA GGT GGT GAA G-3', R: 5'-TCC TTG GAG GCC ATG TAG GCC AT-3.'

Reverse transcription-PCR was performed using a TaKaRa RNA PCR Kit (AMV) Version 3.0 (TaKaRa, Otsu, Japan). Products were visualized with ethidium bromide staining. The relative expression of caspase-9, and caspase-3 mRNA was given as the ratio of the target mRNA absorbance value to the β-actin absorbance value. The absorbance of each band was analyzed with Gel-pro 3.0 (Bethesda).

### Western blot analysis of cytochrome c, Caspase-9, and Caspase-3 protein expression in hippocampal neurons {#sec3-8}

Cells were lysed in ice-cold lysis buffer. After centrifugation, the supernatants were collected. Protein samples were then run on sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to a polyvinylidene difluoride container. Membranes were blocked with 5% fat-free milk powder in Tris-buffered saline, incubated at 4°C overnight with mouse anti-rat cytochrome c (1:1 000), Caspase-3 (1:1 000), Caspase-9 (1:1 000), and β-actin (1:1 000) monoclonal antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA). This incubation was followed by probing with goat anti-mouse secondary antibody (1:1 000, Santa Cruz) at 37°C for 1 hour. The protein was visualized with enhanced chemiluminescence solution, scanned, photographed, and the target protein absorbance value to the β-actin absorbance value was analyzed with a gel-image analytical system, Gel-pro 3.0 (Bethesda).

### Statistical analysis {#sec3-9}

Statistical analyses were performed using SPSS 10.0 (SPSS, Chicago, IL, USA) and the results were expressed as mean ± SEM. Differences between the means were determined by one-way analysis of variance followed by a Student-Newman-Keuls test for multiple comparisons. A value of *P* \< 0.05 was considered significant.
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